InsidersTradesSigma
Gentian Diagnostics ASA: management transactions · Norway · Oslo Børs
OSLO:gentian-diagnostics-asaNO·Oslo BørsMcap 870M€
Browse the full insider trade history of Gentian Diagnostics ASA, a listed equity based in Norway. Shares are quoted on NO NO, under the authority of Oslo Børs. Market capitalisation: €869.8m. The latest transaction was disclosed on 13 May 2026 — Other. Among the most active insiders: Gentian Diagnostics ASA. The full history is openly available.
22
Insider Decl.
0
Thresholds
€703,164
6 ops.
Buy Volume
€5m
2 ops.
Sell Volume
Financial data
39.50 €
Income statement
Revenue176.5 M€
Gross profit98.2 M€56% margin
Net income13.3 M€7.5% margin
Balance sheet & cash
Market cap869.8 M€
Total debt23.0 M€
Free Cash Flow31.8 M€
Last declaration on 13 May 2026
Declarations22 total
Executives●Other0Oslo
OSLO:673319·details not loaded
Executives●Other11Oslo
€11,0883,115 shares@ €3.55950.0013% mcap100.0% of flow
OptionXOSL
OSLO:666196·
Executives●Other11Oslo
€8,8222,500 shares@ €3.52880.0010% mcap100.0% of flow
OptionXOSL
OSLO:665812·
Executives●Other11Oslo
€10,6503,000 shares@ €3.55010.0012% mcap100.0% of flow
OptionXOSL
OSLO:665709·
Executives●Purchase0Oslo
€580,046180,000 shares@ €3.2225
ShareXOSL
OSLO:617577·
Ideal exit: 26 Jan 2025 (T+270)
Executives●Purchase0Oslo
€89,22120,000 shares@ €4.4611
ShareXOSL
OSLO:569996·
Ideal exit: 26 May 2023 (T+270)
Executives●Purchase0Oslo
€9,9992,166 shares@ €4.6166
ShareXOSL
OSLO:569842·
Ideal exit: 23 May 2023 (T+270)
Executives●Purchase0Oslo
€3,566800 shares@ €4.4579
ShareXOSL
OSLO:569751·
Ideal exit: 22 May 2023 (T+270)
Executives●Purchase0Oslo
€20,3313,636 shares@ €5.5916
ShareXOSL
OSLO:555151·
Ideal exit: 25 Nov 2022 (T+270)
Executives●Other0Oslo
€647,230100,000 shares@ €6.4723
ShareXOSL
OSLO:540725·
22 of 22 declarations
